BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 043701
(78 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 45.1 bits (105), Expect = 1e-05, Method: Composition-based stats.
Identities = 30/78 (38%), Positives = 44/78 (56%), Gaps = 2/78 (2%)
Query: 2 ELWEFDFARIAKATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGME-EL 60
+L F + A+DNFS+ N LG G FG VYK L + +VKRL + QG E +
Sbjct: 24 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLV-AVKRLKEERXQGGELQF 82
Query: 61 KNEVTLIFVSNYRLLLHM 78
+ EV +I ++ +R LL +
Sbjct: 83 QTEVEMISMAVHRNLLRL 100
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 42.4 bits (98), Expect = 6e-05, Method: Composition-based stats.
Identities = 29/78 (37%), Positives = 43/78 (55%), Gaps = 2/78 (2%)
Query: 2 ELWEFDFARIAKATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGME-EL 60
+L F + A+DNF + N LG G FG VYK L + +VKRL + QG E +
Sbjct: 16 QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLV-AVKRLKEERTQGGELQF 74
Query: 61 KNEVTLIFVSNYRLLLHM 78
+ EV +I ++ +R LL +
Sbjct: 75 QTEVEMISMAVHRNLLRL 92
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 32.0 bits (71), Expect = 0.095, Method: Composition-based stats.
Identities = 22/64 (34%), Positives = 32/64 (50%), Gaps = 8/64 (12%)
Query: 6 FDFARIAKATDNFSSY------NKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEE 59
F F + T+NF NK+GEG FG VYK + ++ +VK+L+ EE
Sbjct: 9 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEE 66
Query: 60 LKNE 63
LK +
Sbjct: 67 LKQQ 70
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 32.0 bits (71), Expect = 0.10, Method: Composition-based stats.
Identities = 22/64 (34%), Positives = 32/64 (50%), Gaps = 8/64 (12%)
Query: 6 FDFARIAKATDNFSSY------NKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEE 59
F F + T+NF NK+GEG FG VYK + ++ +VK+L+ EE
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEE 72
Query: 60 LKNE 63
LK +
Sbjct: 73 LKQQ 76
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 32.0 bits (71), Expect = 0.10, Method: Composition-based stats.
Identities = 22/64 (34%), Positives = 32/64 (50%), Gaps = 8/64 (12%)
Query: 6 FDFARIAKATDNFSSY------NKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEE 59
F F + T+NF NK+GEG FG VYK + ++ +VK+L+ EE
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEE 72
Query: 60 LKNE 63
LK +
Sbjct: 73 LKQQ 76
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 31.6 bits (70), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 18/55 (32%), Positives = 29/55 (52%), Gaps = 1/55 (1%)
Query: 2 ELWEFDFARIAKATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQG 56
E + + +AT+NF +G G FG VYK +L ++ ++KR + S QG
Sbjct: 25 ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV-ALKRRTPESSQG 78
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed
With Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed
With Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed
With Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed
With Kinase Pto
Length = 327
Score = 31.6 bits (70), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 18/55 (32%), Positives = 29/55 (52%), Gaps = 1/55 (1%)
Query: 2 ELWEFDFARIAKATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQG 56
E + + +AT+NF +G G FG VYK +L ++ ++KR + S QG
Sbjct: 25 ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV-ALKRRTPESSQG 78
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 31.2 bits (69), Expect = 0.14, Method: Composition-based stats.
Identities = 15/38 (39%), Positives = 22/38 (57%)
Query: 12 AKATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
A + D + KLGEG +G VYK I + E ++KR+
Sbjct: 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI 67
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 30.8 bits (68), Expect = 0.18, Method: Composition-based stats.
Identities = 16/50 (32%), Positives = 30/50 (60%), Gaps = 2/50 (4%)
Query: 18 FSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
F KLGEG +G VYK I + +I ++K++ S ++E+ E++++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIM 78
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 30.8 bits (68), Expect = 0.21, Method: Composition-based stats.
Identities = 22/64 (34%), Positives = 31/64 (48%), Gaps = 8/64 (12%)
Query: 6 FDFARIAKATDNFSSY------NKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEE 59
F F + T+NF NK GEG FG VYK + ++ +VK+L+ EE
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEE 63
Query: 60 LKNE 63
LK +
Sbjct: 64 LKQQ 67
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 29.6 bits (65), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 19/57 (33%), Positives = 29/57 (50%), Gaps = 1/57 (1%)
Query: 5 EFDFARIAKATDNFSSYNK-LGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEEL 60
EF +R+ DN Y K +G+G FG V+K L + ++K L G +G E+
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM 63
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain
Bound To Appcp From D. Discoideum
Length = 287
Score = 29.6 bits (65), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 19/57 (33%), Positives = 29/57 (50%), Gaps = 1/57 (1%)
Query: 5 EFDFARIAKATDNFSSYNK-LGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEEL 60
EF +R+ DN Y K +G+G FG V+K L + ++K L G +G E+
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM 63
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 29.6 bits (65), Expect = 0.46, Method: Composition-based stats.
Identities = 12/30 (40%), Positives = 21/30 (70%)
Query: 18 FSSYNKLGEGRFGPVYKVILWHSVEIKSVK 47
F+ +++G+G FG VYK I H+ E+ ++K
Sbjct: 21 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIK 50
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase
Domain From D. Discoideum Bound To Appcp
Length = 287
Score = 29.6 bits (65), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 19/57 (33%), Positives = 29/57 (50%), Gaps = 1/57 (1%)
Query: 5 EFDFARIAKATDNFSSYNK-LGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEEL 60
EF +R+ DN Y K +G+G FG V+K L + ++K L G +G E+
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM 63
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 28.9 bits (63), Expect = 0.87, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 18 FSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKN 62
FS ++G G FG VY + E+ ++K++S +Q E+ ++
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 100
>pdb|3IZB|U Chain U, Localization Of The Small Subunit Ribosomal Proteins Into
A 6.1 A Cryo-Em Map Of Saccharomyces Cerevisiae
Translating 80s Ribosome
pdb|3U5C|Y Chain Y, The Structure Of The Eukaryotic Ribosome At 3.0 A
Resolution. This Entry Contains Proteins Of The 40s
Subunit, Ribosome A
pdb|3U5G|Y Chain Y, The Structure Of The Eukaryotic Ribosome At 3.0 A
Resolution. This Entry Contains Proteins Of The 40s
Subunit, Ribosome B
pdb|3J16|D Chain D, Models Of Ribosome-Bound Dom34p And Rli1p And Their
Ribosomal Binding Partners
Length = 135
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 17/55 (30%), Positives = 28/55 (50%), Gaps = 6/55 (10%)
Query: 21 YNKLGEGR-FGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLIFVSNYRL 74
YN + E + F P Y+++ + E ++ K SRQ ++ KN IF + RL
Sbjct: 76 YNSVAEAKKFEPTYRLVRYGLAE-----KVEKASRQQRKQKKNRDKKIFGTGKRL 125
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 27.7 bits (60), Expect = 1.6, Method: Composition-based stats.
Identities = 14/43 (32%), Positives = 24/43 (55%)
Query: 24 LGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTL 66
LGEG+F VYK ++ +I ++K++ G R ++ N L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 60
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
Complexed With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
Complexed With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
Complexed With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
Complexed With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 27.7 bits (60), Expect = 1.9, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 39
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
F82h-L83v- H84d Mutant With An
O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
F82h-L83v- H84d Mutant With An
O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 27.7 bits (60), Expect = 1.9, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 39
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 27.7 bits (60), Expect = 1.9, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 38
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 27.7 bits (60), Expect = 1.9, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 39
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A
Complexed With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A
Complexed With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 27.7 bits (60), Expect = 1.9, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 39
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 27.7 bits (60), Expect = 1.9, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 39
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 27.7 bits (60), Expect = 1.9, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 38
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 27.7 bits (60), Expect = 1.9, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 5 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 40
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 27.3 bits (59), Expect = 1.9, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 38
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 27.3 bits (59), Expect = 2.0, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 38
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 27.3 bits (59), Expect = 2.0, Method: Composition-based stats.
Identities = 19/52 (36%), Positives = 29/52 (55%), Gaps = 10/52 (19%)
Query: 23 KLGEGRFGPVYKVILW--------HSVEIKSVKRLSKGSRQGMEELKNEVTL 66
+LGE RFG VYK L+ +V IK++K ++G + EE ++E L
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR--EEFRHEAML 65
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 27.3 bits (59), Expect = 2.0, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 36
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active
Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 27.3 bits (59), Expect = 2.0, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 37
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 27.3 bits (59), Expect = 2.0, Method: Composition-based stats.
Identities = 19/52 (36%), Positives = 29/52 (55%), Gaps = 10/52 (19%)
Query: 23 KLGEGRFGPVYKVILW--------HSVEIKSVKRLSKGSRQGMEELKNEVTL 66
+LGE RFG VYK L+ +V IK++K ++G + EE ++E L
Sbjct: 33 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR--EEFRHEAML 82
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin
A3 Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin
A3 Complex With The Inhibitor Ro3306
Length = 299
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 36
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 37
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 39
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex
With A Peptide Containing Both The Substrate And
Recruitment Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex
With A Peptide Containing Both The Substrate And
Recruitment Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 36
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 37
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 36
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 37
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+NF K+GEG +G VYK + E+ ++K++
Sbjct: 7 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 40
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+NF K+GEG +G VYK + E+ ++K++
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 43
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 27.3 bits (59), Expect = 2.2, Method: Composition-based stats.
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+NF K+GEG +G VYK + E+ ++K++
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 35
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 27.3 bits (59), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 18 FSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKN 62
FS ++G G FG VY + E+ ++K++S +Q E+ ++
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 27.3 bits (59), Expect = 2.2, Method: Composition-based stats.
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+NF K+GEG +G VYK + E+ ++K++
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 37
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin
B
Length = 289
Score = 27.3 bits (59), Expect = 2.2, Method: Composition-based stats.
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 14 ATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ +NF K+GEG +G VYK + E+ ++K++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 36
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 27.3 bits (59), Expect = 2.2, Method: Composition-based stats.
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+NF K+GEG +G VYK + E+ ++K++
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 35
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 27.3 bits (59), Expect = 2.2, Method: Composition-based stats.
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+NF K+GEG +G VYK + E+ ++K++
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 35
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 27.3 bits (59), Expect = 2.2, Method: Composition-based stats.
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+NF K+GEG +G VYK + E+ ++K++
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 36
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr
160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 27.3 bits (59), Expect = 2.3, Method: Composition-based stats.
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+NF K+GEG +G VYK + E+ ++K++
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 36
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN
OXINDOLE Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN
OXINDOLE Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu-
Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu-
Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Dph- 042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Din- 234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With
Din- 232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin
Binding Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin
Binding Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin
Binding Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin
Binding Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With
Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE
INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE
INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE
INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE
INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor
Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 27.3 bits (59), Expect = 2.3, Method: Composition-based stats.
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+NF K+GEG +G VYK + E+ ++K++
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 35
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 27.3 bits (59), Expect = 2.4, Method: Composition-based stats.
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+NF K+GEG +G VYK + E+ ++K++
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 36
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 27.3 bits (59), Expect = 2.4, Method: Composition-based stats.
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+NF K+GEG +G VYK + E+ ++K++
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 43
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin
A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin
A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 27.3 bits (59), Expect = 2.4, Method: Composition-based stats.
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+NF K+GEG +G VYK + E+ ++K++
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 35
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 27.3 bits (59), Expect = 2.5, Method: Composition-based stats.
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+NF K+GEG +G VYK + E+ ++K++
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI 36
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 26.9 bits (58), Expect = 3.2, Method: Composition-based stats.
Identities = 10/19 (52%), Positives = 13/19 (68%)
Query: 16 DNFSSYNKLGEGRFGPVYK 34
+NF K+GEG +G VYK
Sbjct: 3 ENFQKVEKIGEGTYGVVYK 21
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 26.9 bits (58), Expect = 3.2, Method: Composition-based stats.
Identities = 10/19 (52%), Positives = 13/19 (68%)
Query: 16 DNFSSYNKLGEGRFGPVYK 34
+NF K+GEG +G VYK
Sbjct: 2 ENFQKVEKIGEGTYGVVYK 20
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 26.6 bits (57), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 14/46 (30%), Positives = 24/46 (52%), Gaps = 1/46 (2%)
Query: 22 NKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
++G G FG VYK WH + ++ + Q ++ KNEV ++
Sbjct: 42 QRIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 86
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 65
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 26 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 70
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly
Ligand Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly
Ligand Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 49 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 93
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ +G EL+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ 65
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 59 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 103
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 57 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 101
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ +G EL+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ 65
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 40 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 84
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 99
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3
Beta (Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3
Beta (Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 99
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 144
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 29 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 73
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 77
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b
Inhibitor That Attenuates Hyperactivity In Clock Mutant
Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b
Inhibitor That Attenuates Hyperactivity In Clock Mutant
Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 65
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 77
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 25 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 69
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 65
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 22 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 66
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 65
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ + R EL+
Sbjct: 34 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 78
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 26.6 bits (57), Expect = 3.5, Method: Composition-based stats.
Identities = 13/45 (28%), Positives = 25/45 (55%)
Query: 17 NFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELK 61
+++ +G G FG VY+ L S E+ ++K++ +G EL+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ 65
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 26.6 bits (57), Expect = 3.6, Method: Composition-based stats.
Identities = 14/45 (31%), Positives = 24/45 (53%), Gaps = 1/45 (2%)
Query: 23 KLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
++G G FG VYK WH + ++ + Q ++ KNEV ++
Sbjct: 15 RIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 58
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 26.6 bits (57), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 14/46 (30%), Positives = 24/46 (52%), Gaps = 1/46 (2%)
Query: 22 NKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
++G G FG VYK WH + ++ + Q ++ KNEV ++
Sbjct: 18 QRIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 62
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 26.6 bits (57), Expect = 3.6, Method: Composition-based stats.
Identities = 14/45 (31%), Positives = 24/45 (53%), Gaps = 1/45 (2%)
Query: 23 KLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
++G G FG VYK WH + ++ + Q ++ KNEV ++
Sbjct: 15 RIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 58
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 26.6 bits (57), Expect = 3.6, Method: Composition-based stats.
Identities = 14/45 (31%), Positives = 24/45 (53%), Gaps = 1/45 (2%)
Query: 23 KLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
++G G FG VYK WH + ++ + Q ++ KNEV ++
Sbjct: 20 RIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 63
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 26.6 bits (57), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 14/46 (30%), Positives = 24/46 (52%), Gaps = 1/46 (2%)
Query: 22 NKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
++G G FG VYK WH + ++ + Q ++ KNEV ++
Sbjct: 30 QRIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 74
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 26.6 bits (57), Expect = 3.7, Method: Composition-based stats.
Identities = 14/45 (31%), Positives = 24/45 (53%), Gaps = 1/45 (2%)
Query: 23 KLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
++G G FG VYK WH + ++ + Q ++ KNEV ++
Sbjct: 20 RIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 63
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 14/45 (31%), Positives = 24/45 (53%), Gaps = 1/45 (2%)
Query: 23 KLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
++G G FG VYK WH + ++ + Q ++ KNEV ++
Sbjct: 42 RIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 85
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 14/45 (31%), Positives = 24/45 (53%), Gaps = 1/45 (2%)
Query: 23 KLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
++G G FG VYK WH + ++ + Q ++ KNEV ++
Sbjct: 15 RIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 58
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 14/45 (31%), Positives = 24/45 (53%), Gaps = 1/45 (2%)
Query: 23 KLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
++G G FG VYK WH + ++ + Q ++ KNEV ++
Sbjct: 17 RIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 60
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 14/45 (31%), Positives = 24/45 (53%), Gaps = 1/45 (2%)
Query: 23 KLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
++G G FG VYK WH + ++ + Q ++ KNEV ++
Sbjct: 35 RIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 78
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In
Complex With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In
Complex With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With
A Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With
A Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An
Bromopyridine Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An
Bromopyridine Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With
A Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With
A Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 26.6 bits (57), Expect = 4.0, Method: Composition-based stats.
Identities = 14/45 (31%), Positives = 24/45 (53%), Gaps = 1/45 (2%)
Query: 23 KLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
++G G FG VYK WH + ++ + Q ++ KNEV ++
Sbjct: 43 RIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 86
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 26.6 bits (57), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 14/46 (30%), Positives = 24/46 (52%), Gaps = 1/46 (2%)
Query: 22 NKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
++G G FG VYK WH + ++ + Q ++ KNEV ++
Sbjct: 30 QRIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 74
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 26.2 bits (56), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 19/65 (29%), Positives = 32/65 (49%), Gaps = 10/65 (15%)
Query: 4 WEFDFARIAKATDNFSSYNKLGEGRFGPVYKVILWH-SVEIKSVKRLSKGSRQGMEELKN 62
WE + + + +T ++G G FG VYK WH V +K +K + Q + +N
Sbjct: 31 WEIEASEVMLST-------RIGSGSFGTVYKG-KWHGDVAVKILKVVDPTPEQ-FQAFRN 81
Query: 63 EVTLI 67
EV ++
Sbjct: 82 EVAVL 86
>pdb|2VUW|A Chain A, Structure Of Human Haspin Kinase Domain
Length = 336
Score = 26.2 bits (56), Expect = 5.4, Method: Composition-based stats.
Identities = 20/58 (34%), Positives = 29/58 (50%), Gaps = 6/58 (10%)
Query: 15 TDNFSSYNKLGEGRFGPVYKVILWHS-VEIKSVK----RLSKGSRQG-MEELKNEVTL 66
T+ K+GEG FG V++ I H+ V IK + L GS Q EE+ E+ +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 25.8 bits (55), Expect = 5.9, Method: Composition-based stats.
Identities = 18/52 (34%), Positives = 28/52 (53%), Gaps = 3/52 (5%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
DNF K+GEG G V + S ++ +VK++ +Q E L NEV ++
Sbjct: 77 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIM 125
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 25.8 bits (55), Expect = 5.9, Method: Composition-based stats.
Identities = 18/52 (34%), Positives = 28/52 (53%), Gaps = 3/52 (5%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
DNF K+GEG G V + S ++ +VK++ +Q E L NEV ++
Sbjct: 154 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIM 202
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 25.8 bits (55), Expect = 5.9, Method: Composition-based stats.
Identities = 18/52 (34%), Positives = 28/52 (53%), Gaps = 3/52 (5%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
DNF K+GEG G V + S ++ +VK++ +Q E L NEV ++
Sbjct: 32 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIM 80
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 25.8 bits (55), Expect = 5.9, Method: Composition-based stats.
Identities = 18/52 (34%), Positives = 28/52 (53%), Gaps = 3/52 (5%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
DNF K+GEG G V + S ++ +VK++ +Q E L NEV ++
Sbjct: 34 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIM 82
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 25.8 bits (55), Expect = 6.2, Method: Composition-based stats.
Identities = 18/52 (34%), Positives = 28/52 (53%), Gaps = 3/52 (5%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
DNF K+GEG G V + S ++ +VK++ +Q E L NEV ++
Sbjct: 23 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIM 71
>pdb|3DLZ|A Chain A, Crystal Structure Of Human Haspin In Complex With Amp
pdb|3E7V|A Chain A, Crystal Structure Of Human Haspin With A
Pyrazolo-Pyrimidine Ligand
pdb|3F2N|A Chain A, Crystal Structure Of Human Haspin With An
Imidazo-Pyridazine Ligand
pdb|3FMD|A Chain A, Crystal Structure Of Human Haspin With An Isoquinoline
Ligand
pdb|3IQ7|A Chain A, Crystal Structure Of Human Haspin In Complex With
5-Iodotubercidin
Length = 357
Score = 25.8 bits (55), Expect = 6.2, Method: Composition-based stats.
Identities = 20/58 (34%), Positives = 29/58 (50%), Gaps = 6/58 (10%)
Query: 15 TDNFSSYNKLGEGRFGPVYKVILWHS-VEIKSVK----RLSKGSRQG-MEELKNEVTL 66
T+ K+GEG FG V++ I H+ V IK + L GS Q EE+ E+ +
Sbjct: 40 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 97
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 25.8 bits (55), Expect = 6.3, Method: Composition-based stats.
Identities = 18/52 (34%), Positives = 28/52 (53%), Gaps = 3/52 (5%)
Query: 16 DNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
DNF K+GEG G V + S ++ +VK++ +Q E L NEV ++
Sbjct: 27 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIM 75
>pdb|2WB8|A Chain A, Crystal Structure Of Haspin Kinase
Length = 352
Score = 25.8 bits (55), Expect = 6.6, Method: Composition-based stats.
Identities = 20/58 (34%), Positives = 29/58 (50%), Gaps = 6/58 (10%)
Query: 15 TDNFSSYNKLGEGRFGPVYKVILWHS-VEIKSVK----RLSKGSRQG-MEELKNEVTL 66
T+ K+GEG FG V++ I H+ V IK + L GS Q EE+ E+ +
Sbjct: 35 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 92
>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839
pdb|2IO6|A Chain A, Wee1 Kinase Complexed With Inhibitor Pd330961
Length = 287
Score = 25.4 bits (54), Expect = 7.6, Method: Compositional matrix adjust.
Identities = 13/40 (32%), Positives = 20/40 (50%)
Query: 12 AKATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSK 51
++ T F K+G G FG V+K + I ++KR K
Sbjct: 5 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK 44
>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed
With Inhibitor Pd0407824
Length = 289
Score = 25.4 bits (54), Expect = 7.8, Method: Compositional matrix adjust.
Identities = 13/40 (32%), Positives = 20/40 (50%)
Query: 12 AKATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSK 51
++ T F K+G G FG V+K + I ++KR K
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK 46
>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396
pdb|3BIZ|A Chain A, Wee1 Kinase Complex With Inhibitor Pd331618
pdb|3CQE|A Chain A, Wee1 Kinase Complex With Inhibitor Pd074291
pdb|3CR0|A Chain A, Wee1 Kinase Complex With Inhibitor Pd259_809
Length = 287
Score = 25.4 bits (54), Expect = 7.9, Method: Compositional matrix adjust.
Identities = 13/40 (32%), Positives = 20/40 (50%)
Query: 12 AKATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSK 51
++ T F K+G G FG V+K + I ++KR K
Sbjct: 5 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK 44
>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770
Length = 285
Score = 25.4 bits (54), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 13/40 (32%), Positives = 20/40 (50%)
Query: 12 AKATDNFSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSK 51
++ T F K+G G FG V+K + I ++KR K
Sbjct: 3 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK 42
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 25.4 bits (54), Expect = 8.3, Method: Composition-based stats.
Identities = 18/50 (36%), Positives = 24/50 (48%)
Query: 18 FSSYNKLGEGRFGPVYKVILWHSVEIKSVKRLSKGSRQGMEELKNEVTLI 67
SY K+GEG G V HS +VK + +Q E L NEV ++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIM 96
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 25.4 bits (54), Expect = 8.7, Method: Composition-based stats.
Identities = 11/32 (34%), Positives = 19/32 (59%)
Query: 18 FSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ K+GEG +G V+K + EI ++KR+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRV 35
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 25.4 bits (54), Expect = 8.7, Method: Composition-based stats.
Identities = 11/32 (34%), Positives = 19/32 (59%)
Query: 18 FSSYNKLGEGRFGPVYKVILWHSVEIKSVKRL 49
+ K+GEG +G V+K + EI ++KR+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRV 35
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.322 0.137 0.404
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 2,254,116
Number of Sequences: 62578
Number of extensions: 72312
Number of successful extensions: 414
Number of sequences better than 100.0: 125
Number of HSP's better than 100.0 without gapping: 89
Number of HSP's successfully gapped in prelim test: 36
Number of HSP's that attempted gapping in prelim test: 323
Number of HSP's gapped (non-prelim): 125
length of query: 78
length of database: 14,973,337
effective HSP length: 47
effective length of query: 31
effective length of database: 12,032,171
effective search space: 372997301
effective search space used: 372997301
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 45 (21.9 bits)